Money on the Move: Auron, Frontera, Immunocore and More Reel in New Funds
Auron Therapeutics reels in $48 million to identify novel AI-based cancer targets, Frontera scoops up $160 million for AAV gene therapy and tech manufacturing and MMI scores $75 million for robotic microsurgery.
Alexis Dormandy Briggs Morrison University Of Oxford Oxford Science Enterprises Drug Administration University Of Oxford Startups
Source: biospace.com